top of page

Two Dose Version of Johnson & Johnson Shot 94% Effective Against COVID-19, Study Finds



A two-dose version of Johnson & Johnson's coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday -- making a two-dose regimen of J&J's Janssen vaccine comparable to a two-dose regimen of Moderna's or Pfizer's. Awesome!



Photo Credit: Possessed Photography

 
 
 

Comments


Thanks for submitting!

Stay updated on the latest good newz!

GoodNewzUniversal brings the top positive news about the world, daily. No matter what happens, there is always going to be good news all over the world. This website has assembled it, just for you.

    © 2023 BY ARYAMAN SINHA

    bottom of page